Related by context. Frequent words. (Click for all words.) 76 Smallpox Vaccine 75 Cervical Cancer Vaccine 75 Influenza Vaccine 75 Blood Thinner 74 Bird Flu Vaccine 74 Cholesterol Drug 73 Drug Candidate 73 Recombinant Human 73 Gastric Cancer 72 Drug Resistant 72 Malaria Vaccine 72 Lung Cancer Patients 72 Diabetic Patients 71 Clinical Trial Results 71 FDA Accepts 71 Overactive Bladder 71 Pulmonary Arterial Hypertension 71 Metastatic Colorectal Cancer 71 Phase III Trial 71 Flu Vaccines 71 Generic Version 70 Well Tolerated 70 FDA Clears 70 Phase III Clinical Trial 69 Hepatitis C Virus 69 Patients Undergoing 69 Swine Flu Vaccine 69 Cancer Treatments 69 Diet Pill 69 Prostate Cancer Patients 69 Autoimmune Disease 69 Prostate Cancer Treatment 69 Advanced Prostate Cancer 69 Monoclonal Antibody 69 Initiate Phase 68 Heart Failure Patients 68 Patients Treated 68 Elderly Patients 68 Brain Cells 68 Completes Enrollment 68 Cold Medicines 68 Anthrax Vaccine 68 Insulin Resistance 68 II Clinical Trial 68 Chronic Hepatitis C 68 Positive Opinion 68 FDA Warns 68 Ear Infections 67 Reduces Risk 67 Immunogenicity 67 Benign Prostatic Hyperplasia 67 Cardiovascular Events 67 Hormone Therapy 67 Metastatic Melanoma 67 Combination Therapy 67 Pivotal Phase III 67 Breast Cancer Treatment 67 Pivotal Phase 67 Low Dose 67 Allergic Rhinitis 67 Antipsychotic 67 Cancer Vaccine 67 Increases Risk 67 Boceprevir 67 Patient Enrollment 67 FDA Approves 67 Chronic Lymphocytic Leukemia 66 Pivotal Trial 66 Atopic Dermatitis 66 Inhibits 66 Vitamin D Deficiency 66 Kidney Stones 66 Adalimumab 66 Preclinical Data 66 Small Molecule 66 Monoclonal Antibodies 66 Gum Disease 66 Venous Thromboembolism 66 Blood Vessels 66 Urinary Incontinence 66 Flu Vaccine 66 Drug Makers 66 Patent Covering 66 Monotherapy 65 Extended Release 65 Regimens 65 Cethromycin 65 Increased Risk 65 Meta Analysis 65 Aliskiren 65 Botulinum Toxin 65 Systematic Review 65 Cancer Vaccines 65 Embryonic Stem Cells 65 Biosimilar 65 Brain Tumors 65 Treatable 65 Dasatinib 64 Pirfenidone 64 Study Demonstrates 64 Immune Response